PERMIT has launched a brief survey to to map patient stratification strategies currently undertaken by industry. It will contribute to a better understanding of the challenges and opportunities in the translational development phase of personalised medicine clinical trials
An abstract about PERMIT's scoping review was selected by the Cochrane Colloquium.
WP2 has now finalized the protocol for the PERMIT Scoping Review. It is now available on Zenodo.
The official kick-off meeting of the PERMIT project took place on Friday, January 24th in Paris, France. All consortium participants and partners attended, and actively participated in discussions on all seven project work packages.
ICPerMed has developed a vision of how the use of personalised medicine approaches will promote 'next-generation' medicine in 2030.
The PERsonalised MedicIne Trials (‘PERMIT’) project on methodological standards for personalised medicine research has received a positive funding.
